More and more off-label, criminal use of antipsychotics
Antipsychotic use is dramatically increasing and beyond psychosis symptoms The use of antipsychotics is rapidly increasing and most of it is ‘off-label’, non-approved use.
Antipsychotic use is dramatically increasing and beyond psychosis symptoms The use of antipsychotics is rapidly increasing and most of it is ‘off-label’, non-approved use.
The Washington Post report found that government attempts to ban to indiscriminate use of antipsychotics for elderly dementia patients had resulted in their use being replaced by anticonvulsant medications that could be used for the treatment of epilepsy.
The chance ‘discovery’ of psychotropic drugs saved psychiatry from oblivion by masking the subject’s lack of scientific foundation.
When the first antipsychotic, chlorpromazine, emerged in the 1950s it was gleefully described by psychiatrists as a ‘chemical lobotomy’ – as though this was something to aim for.
“It may be less of a question of patients experiencing fluoxetine-induced suicidal ideation than patients feeling that ‘death is a welcome result’ when the acutely discomforting symptoms of akathisia are experienced on top of already distressing…